MAXCYTE INC. (MXCT) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-01-10
4:48 pm
Sale
2023-01-0513GMaxCyte, Inc.
MXCT
Casdin Capital LLC9,220,000
9.020%
-4,751,334decrease
(-34.01%)
Filing
History
2022-02-15
2:06 pm
Purchase
2022-02-1413GMaxCyte, Inc.
MXCT
BAMCO INC /NY/5,131,834
5.070%
5,131,834increase
(New Position)
Filing
History
2022-02-11
10:59 am
Purchase
2021-12-3113GMaxCyte, Inc.
MXCT
Sofinnova Crossover I SLP5,110,693
5.100%
5,110,693increase
(New Position)
Filing
History
2022-02-04
4:12 pm
Purchase
2021-12-3113GMaxCyte, Inc.
MXCT
BlackRock Inc.
BLK
6,842,960
6.800%
6,842,960increase
(New Position)
Filing
History
2021-08-03
5:16 pm
Purchase
2021-07-2913GMaxCyte, Inc.
MXCT
Casdin Capital LLC13,971,334
14.200%
13,971,334increase
(New Position)
Filing
History
Goto Prev, 0, 1